Genomic Health, Inc., a leader in precision medicine, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2000, the company has made significant strides in the field of genomic testing, particularly in oncology, with its innovative assays that help guide treatment decisions for cancer patients. The company’s flagship products, including the Oncotype DX® test, are designed to assess the likelihood of cancer recurrence and the potential benefit of chemotherapy, setting them apart in the personalised medicine landscape. Genomic Health has established a strong market position, recognised for its commitment to improving patient outcomes through advanced genomic insights. With numerous accolades and a robust portfolio, Genomic Health continues to shape the future of cancer care.
We don't have data for Genomic Health, Inc., but we can show you information about their parent organization instead.
View parent company